Universal Health Services Inc (UHS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Universal Health Services Inc   (NYSE: UHS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Universal Health Services Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Universal Health Services Inc's ROI in the second quarter of 2026?
Universal Health Services Inc achieved a return on average invested assets (ROI) of 12.79 % in its second quarter of 2026, this is above UHS's average return on investment of 8.69%.
Universal Health Services Inc s investments during the 12 months ending in the second quarter of 2026 are valued at $12 billion

ROI fell compared to the first quarter of 2026, despite the net income growth of 1.65% from the first quarter of 2026.

Within the Healthcare sector 18 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 544 to 549.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 6.04 % 5.45 % 6.37 % 4.73 % 4.1 %
Y / Y Net Income Change TTM 20.43 % 27.02 % 68.42 % 149.96 % 337.33 %
Investment (TTM) in Millions 12,712 11,557 12,209 11,997 11,687
Return On Investment (TTM) 12.79 % 13.05 % 12.76 % 12.07 % 11.26 %
UHS's Overall Ranking # 549 # 544 # 509 # 651 #
Seq. Investment Change TTM 2.16 % 0.13 % 2.12 % 1.52 % 1.59 %
Seq. Net Income Change TTM 0.13 % 2.45 % 7.91 % 8.79 % 5.6 %
Net Income (TTM) in Millions 1,550 1,548 1,511 1,400 1,287




Return On Investment UHS's Ranking
Within: No.
Industry # 2
Sector # 19
Overall # 549

Return On Investment Statistics
High Average Low
13.83 %
8.69 %
5.85 %
(Mar 31 2026)   (Dec 31 2022)







Financial Statements
Universal Health Services Inc's II. Quarter Investments $ 12,712 Millions UHS's Balance sheet
Universal Health Services Inc's II. Quarter Income $ 365 Millions Quarterly UHS's Income Statement
UHS's Income by Division See UHS's Income by Division


UHS Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 11,414 11,227 10,988 10,697 11,115
Y / Y Investment Growth 1.66 % 2.18 % 2.72 % -3.76 % 1.04 %
Net Income in Millions 1,511 1,163 719 657 988
Y / Y Net Income Growth 29.93 % 61.7 % 9.49 % -33.48 % 3.66 %
Annual Return On Investment 13.24 % 10.36 % 6.55 % 6.14 % 8.89 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 13.24 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
UHS's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for UHS's Competitors
Subscribers only: Roi for Universal Health Services Inc's Suppliers
Subscribers only: Return On Investment for UHS's Customers

Other Ratios
UHS's Roa UHS's Inventory Turnover Ratio UHS's Growth Rates UHS's Dividend Statistics
UHS's Profitability Ratios UHS's Asset Turnover Ratio UHS's Dividend Growth
UHS's Roe UHS's Valuation Ratios UHS's Financial Strength Ratios UHS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %


Date modified: 2026-09-12T06:14:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.